You are here: Industry Insights > Mylan

News List

Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn expresspharma
September 17, 2020
Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS.
Mylan Pays $763M for Aspen's Thrombosis Business in Europe contractpharma
September 15, 2020
Mylan N.V. has reached an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for approximately $763 million, subject to customary closing conditions ...
US FDA issues warning to Mylan for Telangana plant expresspharma
September 03, 2020
The US FDA has issued a warning to Mylan after the inspection of its plant in Pashamylaram, Telangana. The inspection was from February 24 to 28 this year after which the drug regulator had issued a Form 483.
Mylan Recalls Four Lots of Amiodarone HCl Injection, Tranexamic Acid Injection americanpharmaceuticalreview
September 02, 2020
Mylan announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP 450 mg/9 mL, packaged in cartons of 10 single-dose 9 mL vials and..
Mylan, Biocon Biologics Announce Launch of Semglee in U.S. americanpharmaceuticalreview
September 01, 2020
Mylan and Biocon Biologics India announced the U.S. launch of Semglee™ (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with...
Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US expresspharma
September 01, 2020
Mylan is offering Semglee at a wholesale acquisition cost (WAC) of $147.98 per package of five 3ml pens and $98.65 per 10ml vial.
Lupin and Mylan launch Nepexto, biosimilar etanercept in German market expresspharma
August 27, 2020
Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective treatment option for several chronic inflammatory diseases.
Mylan announces launch of generic version of Biogen’s Tecfidera expresspharma
August 20, 2020
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS).
Mylan receives DCGI approval in India for TB drug, Pretomanid expresspharma
July 23, 2020
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years.
Mylan, Fujifilm Kyowa Kirin Biologics Announce FDA Approval of Hulio americanpharmaceuticalreview
July 21, 2020
Mylan and Fujifilm Kyowa Kirin Biologics announced the U.S. Food and Drug Administration (FDA) has approved Hulio® (adalimumab-fkjp), a biosimilar to AbbVie's Humira® (adalimumab).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page